跳至主要内容
临床试验/EUCTR2018-001597-16-FI
EUCTR2018-001597-16-FI进行中(未招募)1 期

Efficacy of botulinum toxin in treating temporomandibular disorders

Sitnikova Victoria0 个研究点目标入组 60 人开始时间: 2018年5月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -60 adult patient (males and females) diagnosed TMD according to DC/TMD international consortium: myalgia, local myalgia, myofascial pain, myofascial pain with referral.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Subjects are not receiving any other TMD-treatments and from the previous BTX treatment should have been at least 6 months passed
  • -Other disturbing factors such as CNS drugs, alcoholism, heavy smoking, mental illness, diseases that might cause imbalance of the joint will be excluded
  • -No pregnant women

研究者

发起方
Sitnikova Victoria

相似试验